Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Catalent Massachusetts, LLC
EIR
•Catalent Massachusetts, LLC•November 30, 2021

Catalent Massachusetts, LLC – FDA EIR, Nov 30, 2021

Record Details

An FDA inspection of Catalent Massachusetts, LLC, located in Chelsea, MA, was conducted from November 8 to November 30, 2021. This routine inspection, part of the OPQO Division I Workplan for FY-22 under Compliance Program 7356.002 for Drug Manufacturing, focused on the company's contract manufacturing operations, specifically for Inbrija (Levodopa Inhalation Powder) Capsules, and also served as a follow-up to a previous records request. Catalent had acquired this facility and its personnel from Acorda Therapeutics, Inc. in February 2021, and its primary client remains Acorda for Inbrija production and testing. At the inspection's conclusion, a four-item FDA Form 483, detailing "Inspectional Observations," was issued to General Manager Gordon Ashton. While a comprehensive list of all four observations is not provided, one noted concern involved inconsistent procedures and inappropriate or missing contact times for cleaning agents used in manufacturing areas. Management acknowledged these concerns. In response to the observations, Catalent management committed to submitting a detailed written reply to the FDA within fifteen business days, outlining their corrective actions. No refusals or sample collections occurred during the inspection.

Company
Catalent Massachusetts, LLC
Inspection date
November 30, 2021
Product type
drugs
Office
Division of Pharmaceutical Quality Operations I
People
  • Daniel L. Zheng (M.S., Consumer Safety Officer at FDA)
  • Leanna M. Slarsky (Investigator)
View Company Profile

ID · 83021e31-21fd-4de5-9070-fd2b59140cee

Violation Codes3
21 CFR 4FD&C Act 704(a)(4)21 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Catalent Massachusetts, LLC
  • 483 - 2026-04-07April 7, 2026
  • 483_RESPONSE - 2021-11-30November 30, 2021
  • 483 - 2021-11-30November 30, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Catalent Massachusetts, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.